SCHEMBL4528751

SCHEMBL4528751

CNc1nc(N)nc2cc(-c3c(F)cc(OC)cc3OCCOC)ccc12

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.39
CYP2D6 P10635 1/20 0.37
DRD1 P21728 1/20 0.37
HTR2A P28223 1/20 0.37
ADORA1 P30542 1/20 0.37
SYK P43405 2/20 0.36
KCNH2 Q12809 1/20 0.36
APP P05067 2/20 0.35
NLRP3 Q96P20 2/20 0.35
HRH4 Q9H3N8 1/20 0.34
PTPN1 P18031 2/20 0.34
PIK3CA P42336 2/20 0.34
FGFR1 P11362 1/20 0.34
FLT1 P17948 1/20 0.34
KDR P35968 1/20 0.34
TGFBR1 P36897 1/20 0.34
GRM2 Q14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4511571 0.92 NOS1 (0.36) DHFRCYP2D6DRD1HTR2AADORA1
SCHEMBL4524031 0.90 DHFR (0.43) DHFRCYP2D6DRD1HTR2AADORA1
SCHEMBL4531641 0.89 DHFR (0.46) DHFRCYP2D6DRD1HTR2AADORA1
SCHEMBL4519079 0.88 NLRP3 (0.38) DHFRCYP2D6DRD1HTR2AADORA1
SCHEMBL4529999 0.82 PIK3CA (0.37) DHFRCYP2D6DRD1HTR2AADORA1
Trifluoroacetic Acid SCHEMBL4524745 0.81 NOS1 (0.35) DHFRCYP2D6DRD1HTR2AADORA1
SCHEMBL4524484 0.78 PTPN1 (0.52) DHFRCYP2D6PTPN1
SCHEMBL4533461 0.78 DHFR (0.57) DHFRCYP2D6PTPN1
SCHEMBL4527908 0.77 PTPN1 (0.50) DHFRCYP2D6APPPTPN1TGFBR1
SCHEMBL4526578 0.77 KCNH2 (0.41) DHFRCYP2D6DRD1HTR2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105477-A1 Quinazoline Protein Tyrosine Phosphatase Inhibitors BERTHEL STEVEN JOSEPH 2009-04-23 US claimed
US-20060211715-A1 Quinazoline protein tyrosine phosphatase inhibitors BERTHEL STEVEN J 2006-09-21 US claimed
US-20090105477-A1 Quinazoline Protein Tyrosine Phosphatase Inhibitors BERTHEL STEVEN JOSEPH 2009-04-23 US disclosed
US-20090105477-A1 Quinazoline Protein Tyrosine Phosphatase Inhibitors BERTHEL STEVEN JOSEPH 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105477-A1 Quinazoline Protein Tyrosine Phosphatase Inhibitors PTPN5, PTPN1, PTPN7 DHFR 2071/4885CYP2D6 1228/4885DRD1 4516/4885
US-20060211715-A1 Quinazoline protein tyrosine phosphatase inhibitors PTPN5, PTPN1, PTPN7 DHFR 2071/4885CYP2D6 1228/4885DRD1 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.